tandospirone has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jitoku, D; Kurumaji, A; Shiwaku, H; Tamura, T | 1 |
| Inanaga, K; Kuniyoshi, M; Nishi, S; Ohyama, S | 1 |
| Kurachi, M; Matsui, M; Meltzer, HY; Nohara, S; Sumiyoshi, T; Uehara, T; Yamashita, I | 1 |
1 trial(s) available for tandospirone and Chronic Disease
| Article | Year |
|---|---|
Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Female; Humans; Isoindoles; Male; Memory; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Schizophrenic Psychology; Serotonin Receptor Agonists; Wechsler Scales | 2000 |
2 other study(ies) available for tandospirone and Chronic Disease
| Article | Year |
|---|---|
Effect of Tandospirone, a Partial Agonist of the 5-HT1A Receptor, in a Patient With Chronic Poststroke Emotional Incontinence With Anxiousness.
Topics: Affective Symptoms; Aged; Anxiety; Chronic Disease; Humans; Isoindoles; Male; Piperazines; Pyrimidines; Serotonin 5-HT1 Receptor Agonists; Stroke | 2019 |
[Postherpetic neuralgia alleviated by an SSRI fluvoxamine: two cases of PHN accompanied with depression were treated with fluvoxamine].
Topics: Aged; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Herpes Zoster; Humans; Isoindoles; Neuralgia; Piperazines; Pyrimidines; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome | 2004 |